Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Pharmacist and patient in a pharmacy consultation room

The Murray review: moving in the right directionSubscription

On 20 December 2016, six days after the long-awaited report by the King’s Fund’s Richard Murray on the provision of clinical services in community pharmacy was published, health minister David Mowat described the review as “an essential road map that sets out how we are going to move the community pharmacy network away from a remuneration model”.

Amniocentesis

Preconception care: genetic and pre-existing conditionsSubscription

Pharmacists and healthcare professionals can provide appropriate and comprehensive preconception care by identifying couples who are at risk of having a baby with a genetic or chromosomal malformation and can empower the couple by giving them enough knowledge to make informed decisions.

David Mowat, UK health minister

Murray review of community pharmacy services will ‘direct’ government policy, says health minister

UK health minister David Mowat says that the Murray review into the provision of community pharmacy services will “direct” government policy.

More news

Amniocentesis

Preconception care: genetic and pre-existing conditionsSubscription

Pharmacists and healthcare professionals can provide appropriate and comprehensive preconception care by identifying couples who are at risk of having a baby with a genetic or chromosomal malformation and can empower the couple by giving them enough knowledge to make informed decisions.

More learning articles

Sophie Riddell with a client

How pharmacists can become aesthetic practitionersSubscription

As demand for non-surgical cosmetic procedures increases, Saša Jankovic finds out about training requirements, industry regulation, as well as the benefits pharmacists can provide patients by offering these services.

Annie Pannelay, principal consultant for healthcare practice at the Economist Intelligence Unit

What pharmacist Annie Pannelay does as a consultant for a media companySubscription

Annie Pannelay works in the healthcare practice of the Economist Intelligence Unit — as a pharmacist, not a journalist.

More career articles

Robbie Turner director for RPS England

RPS local engagement: your chance to get involvedSubscription

The Royal Pharmaceutical Society is keen to develop a new model for local engagement and is calling on members to give their views on what they would like in future.

More Your RPS

Pharmacist and patient in a pharmacy consultation room

The Murray review: moving in the right directionSubscription

On 20 December 2016, six days after the long-awaited report by the King’s Fund’s Richard Murray on the provision of clinical services in community pharmacy was published, health minister David Mowat described the review as “an essential road map that sets out how we are going to move the community pharmacy network away from a remuneration model”.

Photopharmacology concept with light spectrum and switch

Photopharmacology: using light to activate drugsSubscription

 Drugs that contain synthetic light-switching molecules could help target therapies to particular parts of the body, limiting side effects. Researchers have started using this approach to tackle blindness, cancer, diabetes, and antibiotic resistance, but questions remain about the clinical practicality of the field.

Collage of the key players in the pharmacy funding cuts

Pharmacy funding cuts: the story so farSubscription

When the Department of Health revealed in December 2015 that it was planning to cut community pharmacy funding in England by 6%, shockwaves ran through the sector. Now, over a year later, community pharmacies are beginning to feel the impact.

More features

Special report

Summary care record

A one-off £200 payment will be awarded to each England-based community pharmacy contractor when the summary care record (SCR) service is activated before 31 March 2017, and pharmacies using the SCR can earn points through the Quality Payments scheme — which could be worth up to £1,280. Learn more about the service and how to use it with The Pharmaceutical Journal’s special report on the SCR.

Read on

White Paper

Headaches in children: An unmet need

Pharmacist Christine Glover discusses the need for greater awareness and better management of paediatric headache in community pharmacy.

This article was commissioned, briefed and fully funded by RB.

Read on

Illustration showing alarm due to rise of antimicrobial resistant bacteria from biocides and heavy metals

How chemicals and heavy metals contribute to antimicrobial resistanceSubscription

Evidence is emerging that biocides and heavy metals all contribute to the growing problem of antimicrobial resistance.

Illustration of fractured bones and drugs

Why some patients are reluctant to take osteoporosis drugsSubscription

There are a number of factors that contribute to patients’ fear and reluctance to take osteoporosis drugs, leaving them at increased risk of fractures.

More opinion

Infographic showing a decade of community pharmacy funding in England and timeline of events

A decade of community pharmacy funding in EnglandSubscription

Community pharmacies in England dispense 174 million more prescription items annually than in 2010, a figure that is predicted to rise further. Despite this, total funding for the community pharmacy contract is heading back towards 2010 levels.

More infographics

Micrograph of Clostridium difficile bacteria

Clostridium difficile: diagnosis and treatment update

There are around 12,000 cases of Clostridium difficile infection (CDI) each year in the UK and during 1999 to 2007, deaths from CDI peaked at around 4,000 per year. This article summarises diagnosis and management, as well as the current therapeutic options for CDI, including faecal microbiota transplant.

coloured scanning electron micrograph (SEM) of bacterial blood infection (sepsis) caused by a rod shaped bacterium (blue)

Sepsis: an update on identification and management Subscription

All healthcare professionals, including pharmacists, should be aware of the clinical features and management of sepsis. This article summarises the recent changes in the definition of sepsis in adults, as well as its management.

More CPD modules

The rise of patient-centred technologies in community pharmacy

2017 could see a rise in patient-centred technologies across pharmacy. Martin Hao, managing director at Healthera, a new medicines management app, looks at the reasons behind the trend.

Brexit illustration with divided euro coin on European map

Preserving research and development in a post-Brexit era

Additional funding for R&D post-Brexit is a welcome move from the UK government, but there are other related issues to consider as well.

Other blogs

Research article

Molecular model of C-reactive protein

Evaluating a point-of-care C-reactive protein test to support antibiotic prescribing decisions in a general practiceSubscription

Abstract Background: C-reactive protein (CRP) is a marker of infection and inflammation. It is high in bacterial infections but very low or close to zero in viral infections. The National Institute for Health and Care Excellence (NICE), England and Wales’s health technology assessment body, has issued guidance on pneumonia in adults; it recommends point-of-care (POC) CRP analysers when clinical assessment is inconclusive. If the CRP level ...

Oral anticoagulant therapy and INR blood test monitor

Assessing the impact of a targeted pharmacist-led anticoagulant review clinicSubscription

Abstract Background: Local guidance, supported by the 2014 National Institute for Health and Care Excellence (NICE) guideline CG180 for atrial fibrillation (AF), recommends that patients receiving inadequate anticoagulation with a vitamin K antagonist (VKA), including time in therapeutic range (TTR) of <65%, should be reassessed. These patients were identified by the anticoagulation monitoring service (AMS) and highlighted to GPs for review. ...

Close-up of a person taking a dry-blood spot test

Integrating community pharmacy testing for hepatitis C with specialist careSubscription

Abstract Background:  Many patients with hepatitis C virus (HCV) infection lie undiagnosed and a significant proportion of patients that have been identified are disengaged from specialist services. The Isle of Wight (IOW) typifies this issue, with an estimated 200 undiagnosed patients with HCV infection and a small number of known cases engaged with specialist services. Aim:  To reduce the burden of undiagnosed HCV ...

NHS pharmacist discusses patient care with a nurse on a ward

Examining the emerging roles for pharmacists as part of the urgent, acute and emergency care workforceSubscription

By , , , ,

Abstract In the future urgent, acute and emergency medicine clinical workforce, new models of care and care delivery need to be developed, in order to maintain and enhance standards of safe and accessible patient care. A departure from traditional (doctor-led) approaches to workforce planning, and an understanding of scope and governance surrounding emerging clinical roles is necessary to develop a sustainable, multi-skilled workforce across primary, community and secondary ...

More perspective articles

Image 1 shows a normal spine and image 2 shows a spine affected by spondylitis

TNFα-inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritisSubscription

By , , , , , , , , ,

Abstract Spondyloarthropathy refers to a group of articular inflammatory diseases that share common genetic, clinical and radiological features in addition to their association with human leucocyte antigen (HLA)-B27 antigen. The aim of therapeutic management of patients with spondyloarthritis is to improve quality of life, control the symptoms of articular inflammation, prevent the structural damage of joints, and preserve the functional abilities, autonomy and social participation ...

More review articles

A reference you need

British National Formulary, 71st edition

Up-to-date, practical guidance on prescribing, dispensing, administering medicines and current best practice relating to the uses of medicines, as well as legal and professional guidelines.

Order your copy

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.